OTC · Financial Statements

Linike Medical Group Ltd (LNMG) Financial Statements

$0.01 OTC: LNMG Market Cap $2.70M

Linike Medical Group Ltd most recently reported annual revenue of $11.0M, net profit of $3.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$9.0M$13.0M$11.0M
Operating Profit$0$0$1.0M$0$3.0M
Net Profit$0$0$1.0M$0$3.0M
EPS$0.00$0.00$0.00$0.00$0.00
Op Margin——11.1%-1.9%28.9%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$0$0$55.0M$56.0M$58.0M
Total Liabilities$0$0$20.0M$21.0M$20.0M
Cash$0$0$1.0M$1.0M$0
Borrowings$0$0$17.0M$18.0M$17.0M

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$0$0$-2.0M$-1.0M$0
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$0$0$2.0M$0$0
Net Cash Flow$0$0$1.0M$0$0
Free Cash Flow$0$0$-2.0M$-1.0M$0

Valuation & Return Ratios

MetricValue
PEG Ratio0.01
EV / EBITDA5.31
FCF Yield-91.69%
Quick Ratio3.08
Interest Coverage0.00
Return 1Y-66.03%
Return 3Y-99.89%
Return 5Y—

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens featuring this stock

High ROE Consumer Cyclical StocksLow P/E Consumer Cyclical StocksHigh Net Margin Consumer Cyclical StocksDividend Consumer Cyclical StocksLow Debt Consumer Cyclical StocksAll stock screens
LNMG Overview LNMG Dividend Run Stock Screener